Budget impact analysis of the percutaneous septal occluder for treatment of ostium secundum atrial septal defects in the Brazilian Unified National Health System

被引：0

作者：

Simoes e Senna, Katia Marie ^{[1
]}

Sarti, Flavia Mori ^{[2
]}

Santos da Costa, Marcia Gisele ^{[1
]}

Nita, Marcelo Eidi ^{[2
]}

Santos, Marisa da Silva ^{[1
]}

Tura, Bernardo Rangel ^{[1
]}

Correia, Marcelo Goulart ^{[1
]}

机构：

[1] Inst Nacl Cardiol, Rio De Janeiro, Brazil

[2] Univ Sao Paulo, Sao Paulo, Brazil

来源：

CADERNOS DE SAUDE PUBLICA | 2015年 / 31卷 / 08期

关键词：

Heart Septal Defects; Septal Occluder Device; Biomedical Technology; Thoracic Surgery; Health Evaluation; CLOSURE; DEVICE;

D O I：

10.1590/0102-311X00039014

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

The aim of this study was to perform a budget impact analysis on the adoption of percutaneous occlusion of ostium secundum atrial septal defects in the Brazilian Unified National Health System. Costs were collected using micro-costing technique from medical records for each treatment technique (conventional surgery versus percutaneous septal occluder) at a public federal hospital specialized in high-complexity cardiology. The analysis showed that expenditures associated with percutaneous occlusion were lower than with conventional surgery, and sensitivity analysis confirmed the cost reduction in several scenarios, showing a significant budget impact with a 30% adoption rate for the percutaneous occluder (savings of approximately 1.5 million dollars per year). The study indicates that the adoption of the percutaneous septal occluder would mean cost savings of approximately 3.5 million dollars for the Brazilian public health system.

引用

页码：1756 / 1764

页数：9

共 18 条

[1] Closure of atrial septal defects:: Is there still a place for surgery?
Bové, T
François, K
De Groote, K
Suys, B
DeWolf, D
Van Nooten, G
[J]. ACTA CHIRURGICA BELGICA, 2005, 105 (05) : 497 - 503
[2] Brown S C, 2004, Cardiovasc J S Afr, V15, P28
[3] Effectiveness of the Amplatzer™ device for transcatheter closure of an ostium secundum atrial septal defect
Cardoso, Cristiano Oliveira
Rossi Filho, Raul Ivo
Machado, Paulo Renato
Galant Francois, Lisia M.
Horowitz, Estela S. K.
Sarmento-Leite, Rogerio
[J]. ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2007, 88 (04) : 384 - 389
[4] Du ZD, 2002, J AM COLL CARDIOL, V39, P1836, DOI DOI 10.1016/S0735-1097(02)01862-4
[5] Indications for Cardiac Catheterization and Intervention in Pediatric Cardiac Disease A Scientific Statement From the American Heart Association
Feltes, Timothy F.
Bacha, Emile
Beekman, Robert H., III
Cheatham, John P.
Feinstein, Jeffrey A.
Gomes, Antoinette S.
Hijazi, Ziyad M.
Ing, Frank F.
de Moor, Michael
Morrow, W. Robert
Mullins, Charles E.
Taubert, Kathryn A.
Zahn, Evan M.
[J]. CIRCULATION, 2011, 123 (22) : 2607 - 2652
[6] Closure of secundum atrial septal defects with the Amplatzer septal occluder device: Techniques and problems
Harper, RW
Mottram, PM
McGaw, DJ
[J]. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2002, 57 (04) : 508 - 524
[7] Prospective comparison of costs and short term health outcomes of surgical versus device closure of atrial septal defect in children
Hughes, ML
Maskell, G
Goh, TH
Wilkinson, JL
[J]. HEART, 2002, 88 (01) : 67 - 70
[8] Erosion of an Amplatzer Septal Occluder Device Into the Aortic Root
Kamouh, Abdallah
Osman, Mohammed Najeeb
Rosenthal, Noah
Blitz, Arie
[J]. ANNALS OF THORACIC SURGERY, 2011, 91 (05) : 1608 - 1610
[9] Kim Jeffrey J, 2002, Med Sci Monit, V8, pCR787
[10] National Institute for Health and Clinical Excellence, 2004, END CLOS ATR SEPT DE

← 1 2 →